21 September, 2012    london , United Kingdom
Molecular Pharming is on the brink of taking off! After two decades of development and academic proofs of principle, a number of recent advances have moved the technology rapidly towards commercialisation. The first products are now being licensed in the USA. The first-in-human clinical trial of a plant derived monoclonal antibody has been performed in Europe. And there has been significant investment into manufacturing facilities around the world.

This meeting will review the progress of the field, highlight major technological advances and scan the horizon for future developments.

Meeting Chair: Professor Julian Ma, St Georges Hospital-University London

Venue

Location: The Penridge Suite
The Penridge Suite is an elegant and modern venue that has been designed in neutral, fresh colours and therefore suiting any colour scheme or theme. A great deal of effort went into making The..
Contact 470 Bowes Road London N11 1NL london , United Kingdom
020 83620881

Related events

Molecular Pharming 21 September, 2012